Low incidence of anaphylactic shock with Pfizer-BioNTech coronavirus vaccine.
“Of these, 21 experienced anaphylaxis (a rate of 11.1 people per one million doses), including 17 in people with a documented history of allergies or allergic reactions, seven of whom had a history of anaphylaxis.”